Dow Up 2.00% Nasdaq Up 1.66%

Cleveland BioLabs, Inc. (CBLI)

-NasdaqCM
3.45 Up 0.03(0.88%) Feb 12, 3:59PM EST
Prev Close:3.42
Open:3.49
Bid:3.44 x 700
Ask:3.46 x 300
1y Target Est:2.00
Beta:-0.346804
Earnings Date:Feb 22 - Feb 26 (Est.)
Day's Range:3.44 - 3.53
52wk Range:1.84 - 7.24
Volume:9,886
Avg Vol (3m):35,131
Market Cap:36.99M
P/E (ttm):313.64
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CBLI

Comparison

Symbol% ChgMkt Cap
CBLIUp 0.88%36.99M
OSIRDown 0.30%229.46M
AZNUp 1.75%74.98B
AMGNUp 2.30%109.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate is Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is developing as a... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback